Table 1.
CDG-341 | CDG-348 | CDG-352 | |
---|---|---|---|
Ancestry | European | European | European |
Gender | Male | Female | Male |
Current Age | 3 years | 3 years | 6 years |
Inheritance | de novo | de novo | de novo |
Nucleotide Change | chrX: 48,768,775_48,768,899 delinsT |
chrX: 48,768,911 C>T |
chrX: 48,762,195 C>T |
cDNA Change | c.15_91+48 delinsA | c.3G>A | c.991G>A |
Protein Change | p.Gly8Serfs∗9 | p.Met1? | p.Val331Ile |
Likely Affect on Protein | Termination | Loss of initiator methionine | Improper positioning in membrane |
Developmental Delay | Yes | Yes | Yes |
Hypotonia | Yes | Yes | Yes |
Seizures | Yes | Yes | No |
Hypsarrhythmia | Yes | Yes | No |
Hypertension | No | No | Yes |
Dysmorphic features | No | Yes | Yes |
Skeletal abnormalities | No | Shortened extremities | Shortened extremities |
Renal | No | No | Acute nephrotic syndrome; requiring dialysis |
Ocular | Nystagmus | Retinitis pigmentosa | Ocular flutter |
Liver dysfunction | No | No | No |
Coagulopathy | Yes | No | No |
Gastrointestinal | No | Strictly G-tube feed | Gastro-esophageal reflux, esophagitis, duodenal perforation |
Recurrent Infections | No | Yes | No |
Microcephaly | No | Yes | Yes |
Brain malformation | Small cerebellum | Thinning of corpus callosum with delayed myelinization | Cerebral hypoplasia/atrophy |